BIOSPECIFICS TECHNOLOGIES CORP Capitalized Contract Cost, Net, Current
BIOSPECIFICS TECHNOLOGIES CORP had Capitalized Contract Cost, Net, Current of $0 as of 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:CapitalizedContractCostNetCurrent · last filed 2020-03-16
- 2019-12-31: Capitalized Contract Cost, Net, Current $0.00.
- 2019-09-30: Capitalized Contract Cost, Net, Current $0.00.
- 2019-06-30: Capitalized Contract Cost, Net, Current $0.00.
- 2019-03-31: Capitalized Contract Cost, Net, Current $0.00.
| Period end | Capitalized Contract Cost, Net, Current |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-09 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-10 |
| 2018-12-31 | $184.93K 10-K · filed 2020-03-16 |
| 2017-12-31 | $1.79M 10-K · filed 2019-04-02 |